BETHESDA, Md.--(BUSINESS WIRE)--Nov. 2, 2005--RegeneRx Biopharmaceuticals, Inc. (AMEX:RGN) (www.regenerx.com) has launched its new website adding additional investor information and including more graphical content to better describe research results relating to the Company’s TB4 technology platform.
